Clinical relevance of Paliperidone Palmitate three-month intramuscular injection formulation: an Italian Real-World, Retrospective, one-year Mirror Image Study

INTRODUCTION: Paliperidone Palmitate 3-month (PP3M) formulation, introduced in Italy since 2017, is an effective and safety therapeutic option for patients with schizophrenia, clinically stable with 1-month formulation (PP1M). Only a few “Real World” studies investigated the clinical relevance of PP...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanzetto, S., Cirnigliaro, G., Battini, V., Piccoli, E., Vismara, M., Viganò, C., Dell’Osso, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566695/
http://dx.doi.org/10.1192/j.eurpsy.2022.879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566695/
http://dx.doi.org/10.1192/j.eurpsy.2022.879

Ejemplares similares